BADBIR will be at the BAD Annual Meeting in Manchester, 2nd-4th July

Come and visit us on our stand in the exhibition hall, or attend one of our talks:

  • Tues 2nd July; 14:30-15:00: How BADBIR can help answer your research question
  • Weds 3rd July; 09:00-09:15: The effectiveness of adalimumab biosimilars and originator for the treatment of psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
  • Weds 3rd July; 11:15-11:30: Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group
  • Weds 3rd July; 16:01-16:12: Suicide risk in patients with psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)